ELTX
NASDAQ
US
Elicio Therapeutics, Inc. - Common Stock
$10.65
▼ $-0.01
(-0.09%)
Vol 69K
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$139.2M
ROE
-656.6%
Margin
-81.5%
D/E
254.72
Beta
1.19
52W
$5–$13
Wall Street Consensus
8 analysts · Apr 20262
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating
Price Chart
Similar Stocks
KRRO
Korro Bio Inc
$75.4M
NVCT
Nuvectis Pharma Inc
$193.4M
ANIK
Anika Therapeutics Inc
$138.6M
SABS
SAB Biotherapeutics Inc
P/E 9.5
$178.0M
ZNTL
Zentalis Pharmaceuticals Inc
$97.5M
MGNX
MacroGenics Inc
$101.8M
CRBU
Caribou Biosciences Inc
$148.6M
TNXP
Tonix Pharmaceuticals Holding Corp
$199.7M
CRBP
Corbus Pharmaceuticals Holdings Inc
$142.9M
Earnings
Beat rate: 50.0%
Next Report
May 11, 2026
EPS Estimate: $-0.50
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.50 | — | — |
| Dec 2025 | $-0.45 | $-0.45 | +$0.00 |
| Sep 2025 | $-0.56 | $-0.60 | $-0.04 |
| Jun 2025 | $-0.70 | $-0.66 | +$0.04 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -405.5% | -405.5% | -405.5% | -405.5% | -405.5% | -656.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -81.5% | -81.5% | -81.5% | -81.5% | -81.5% |
| Gross Margin | — | 98.5% | 98.5% | 98.5% | 98.5% | 98.5% |
| D/E Ratio | 509.11 | 509.11 | 509.11 | 509.11 | 509.11 | 254.72 |
| Current Ratio | 2.28 | 2.28 | 2.28 | 2.28 | 2.28 | 3.29 |
Key Ratios
ROA (TTM)
-160.7%
P/S (TTM)
4.69
P/B
6.2
EPS (TTM)
$-3.15
CF/Share
$-7.66
52W High
$12.62
52W Low
$4.60
$4.60
52-Week Range
$12.62
How does ELTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
ELTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
4.7
▼
64%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
6.2
▲
151%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
ELTX profitability vs Biotechnology peers
ROE
-656.6%
▼
876%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-81.5%
▲
72%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
98.5%
▲
25%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-160.7%
▼
244%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
ELTX financial health vs Biotechnology peers
D/E ratio
254.7
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
3.3
▼
26%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▲
22%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
ELTX fundamentals radar
ELTX
Peer median
Industry
ELTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ELTX vs peers: key metrics
Latest News
No related news yet